Morvan's syndrome is an autoimmune disorder characterized by central, autonomic, and peripheral hyperactivity with associated thymoma in majority. The clinical features include insomnia, hyperhidrosis, myokymia, dysautonomia and hallucinations. Voltage gated potassium channel (VGKC) namely, leucine-rich glioma inactivated 1 (LGI-1) antibody and contactin-associated protein-like 2 (CASPR-2) antibody are thought to play a pathogenic role in peripheral and central nervous system symptoms in Morvan's syndrome. Electromyography (EMG) is useful in diagnosis of Morvan's syndrome characterized by spontaneous myober activity with various denervation potentials. Computed tomography (CT) scan and Magnetic resonance imaging (MRI) brain is usually normal. Immunosuppressive therapies, encompassing corticosteroids, azathioprine, methotrexate and recently, rituximab, are the mainstay of therapy. Other treatments include PE, IVIG, and thymectomy. We report a rare case of morvan syndrome with typical clinical features along with leucine-rich glioma inactivated 1 (LGI-1) antibody and contactin-associated proteinlike 2 (CASPR-2) antibody positivity successfully treated with intravenous immunoglobulin (IVIG) therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.